Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Solid Tumors × nintedanib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 16 Ovarian Neoplasms 7 Neoplasms 6 Colorectal Neoplasms 4 Recurrence 3 Prostatic Neoplasms 3 Carcinoma, Hepatocellular 3 Breast Neoplasms 3 Uterine Cervical Neoplasms 2 Radiation Pneumonitis 2 Peritoneal Neoplasms 2 Mesothelioma, Malignant 2 Lung Neoplasms 2 Leukemia, Myeloid, Acute 2 Glioblastoma 2 Fallopian Tube Neoplasms 2 Thyroid Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumors 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Rectal Neoplasms 1 Patients With Any Advanced Solid Tumors 1 Ovarian Diseases 1 Oligodendroglioma 1 Neoplasms by Site 1 Neoplasm Metastasis 1 Mesothelioma 1 Melanoma, Cutaneous Malignant 1 Malignant Solid Tumour 1

Interventions

Paclitaxel 14 Gemcitabine 11 atezolizumab 9 Carboplatin 9 pembrolizumab 8 Docetaxel 8 Irinotecan 7 Bevacizumab 7 Cetuximab 6 Sunitinib 5 Leucovorin 5 Injections 5 Fluorouracil 5 Cyclophosphamide 5 Capecitabine 5 olaparib 4 navitoclax 4 liposomal doxorubicin 4 Topotecan 4 Oxaliplatin 4 Nivolumab 4 Erlotinib Hydrochloride 4 temsirolimus 3 spartalizumab 3 pazopanib 3 lenvatinib 3 fludarabine 3 Cisplatin 3 zolbetuximab 2 tocilizumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01349296 2016-05-20

BARIS

University of Cologne

Phase 1 Completed

Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡